Fatal liver failure caused by reactivation of lamivudine-resistant hepatitis B virus: A case report

doi:10.3748/wjg.v13.i6.964

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2030)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

188

HTML

1442

Figures (1-3)

214

Tables (1-1)

186

Sum=2030

Feb 14, 2007 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Feb 14, 2007; 13(6): 964-969
Published online Feb 14, 2007. doi: 10.3748/wjg.v13.i6.964

Full Size Figure Download Figure

Figure 1 Clinical course of our patient. HBV DNA level was quantified by transcription-mediated amplification assay. The levels of HBV DNA started to increase 8 mo after treatment with reappearance of HBeAg. Breakthrough hepatitis developed 12 mo after treatment. The timing of serum sample analysis for mutations is shown by the arrowhead.

Citation: Suzuki Y, Yotsuyanagi H, Okuse C, Nagase Y, Takahashi H, Moriya K, Suzuki M, Koike K, Iino S, Itoh F. Fatal liver failure caused by reactivation of lamivudine-resistant hepatitis B virus: A case report. World J Gastroenterol 2007; 13(6): 964-969
URL: https://www.wjgnet.com/1007-9327/full/v13/i6/964.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i6.964